Neurochemical and behavioural changes in rat models of depression

Croatica Chemica Acta

Volumn 84, Issue 2, 2011, Pages 287-299

  Skelin, Ivan ^a,c   Kovaèević, Tomislav ^a,b   Diksic, Mirko ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^c UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Animal model of depression; Depression; Flinders Resistant line rat; Flinders sensitive line rat; Olfactory bulbectomized rat model of depression

Indexed keywords

EID: 80054109508     PISSN: 00111643     EISSN: 1334417X     Source Type: Journal    
DOI: 10.5562/cca1817     Document Type: Article

References (164)

1. L.L. Judd, Int. Clin. Psychopharmacol, Suppl 4 (1995) 5-10.
2. Erratum in: Int. Clin. Psychopharmacol 11 (2) (1996) 153.
3. R.C. Kessler, P. Berglund, O. Demler, R. Jin, K.R. Merikangas and E.E. Walters, Arch. Gen. Psychiatry 62 (2005) 593-602.
4. Erratum in: Arch. Gen. Psychiatry 62 (2005) 768.
5. DMS-IV, The Diagnostic Statistical Manual of Mental Disor-ders-IV (1994)
6. G. Yadid and A. Friedman, Prog. Brain Res. 172 (2008) 265-86.
7. W.F. Byerley and S.C. Risch, J. Clin. Psychopharmacol. 5 (1985) 191-206.
8. C.A. Naranjo, L.K. Tremblay and U.E. Busto, Prog. Neuropsy-chopharmacol. Biol. Psychiatry 25 (4) (2001) 781-823.
9. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold and L.M. Monteggia, Neuron 34 (2002) 13-25.
10. I.D. Neumann, G. Wegener, J.R. Homberg, H. Cohen, D.A. Slattery, J. Zohar, J.D. Olivier and A.A. Mathé, Prog Neuropsy-chopharmacol Biol Psychiatry (2011)
11. A.B. Fernando and T.W. Robbins, Annu Rev Clin Psychol 7 (2011) 15.1-15.23
12. J.P. Kelly, A.S. Wrynn and B.E. Leonard, Pharmacol. Ther. 74 (1997) 299-316.
13. M.F. O'Neil and N.A. Moore, Human Psychopharmacol. Clin. Exp. 18 (2003) 239-254.
14. J.F. Cryan, A. Markou and I. Lucki, TRENDS in Pharmacol. Sciences 23 (2002) 238-245.
15. P. Willner and P.J. Mitchell, Behav. Pharmacol. 13(2002) 169-188.
16. G.M. Shepherd, Physiological. Reviews. 52 (1972) 864-917.
17. J.D. Jentsch and J.R. Taylor, Psychopharmacology 146 (1999) 373-390.
18. E. Dremencov M.E. Newman, N. Kinor G. Blatman-Jan, C.J. Schindler, D.H. Overstreet and G. Yadid, Neuropharmacol. 48 (2005) 34-42.
19. E. Dremencov, I. Gispan-Herman, M. Rosenstein, A. Mendel-man, D.H. Overstreet, J. Zohar and G. Yadid, Prog. Neuropsy-chopharmacol. Biol. Psychiatry 28 (2004) 141-147.
20. A. Mar, E. Spreekmeester and J Rochford, Psychopharmacology (Berl) 150 (2000) 52-60.
21. D.H. Overstreet and R.W. Russell, Psychopharmacol (Berl) 78 (1982) 150-155.
22. D.H. Overstreet, R.W. Russell, S.C. Helps and M. Messenger, Psychopharmacology (Berl) 65 (1979) 15-20.
23. J.A. Jesberger and J.S. Richardson, Int. J. Neuroscience 38 (1988) 241-265.
24. A.R. Lumia, M.H. Teicher, F. Salchli, E. Ayers and B. Possi-dente, Brain Res. 587 (1992) 181-185.
25. D.H. Overstreet, E. Friedman, A.A. Mathé and G.Yadid, Neuroscien. Biobehav. Rev 29 (2005) 739-759.
26. C.Song and B.E. Leonard, Neuroscien. Biobehav. Rev. 29 (2005) 627-647.
27. N. Nelson, J. Physiology (Paris) 87(1993) 171-178.
28. P. Blier, Eur. Neuropsychopharmacol. 13 (2003) 57-66.
29. H. Sato, I. Skelin, G. Debonnel and M. Diksic, Brain Res. Bull. 75 (2008) 545-55.
30. H. Sato, I. Skelin and M. Diksic, Brain Res. 1345 (2010) 28-44.
31. K. Nishi, K. Kanemaru and M. Diksic, Neurochem. Int. 54 (2009) 299-307.
32. M.Yates, A. Leake, J.M. Cy, A.F. Fairbairn, I.G. McKeith and I.N. Ferrier, Biol. Psychiatry 27(5) (1990) 489-496.
33. J.J. Mann, M.D. Underwood and V. Arango, In: Biology of schizophrenia and affective disease, Watson SJ (Ed). American Psychiatric Press, Washington, 1996, pp 197-221.
34. B. Earley, M. Glennon, M. Lally, B.E. Leonard and J.L. Junien, Human Psychopharmacol. 9 (1994) 397-407.
35. J.H. Meyer, S. Kapur, B. Eisfeld, G.M. Brown, S. Houle, J. DaSilva, A.A. Wilson, S. Rafi-Tari, H.S. Mayberg and S.H. Kennedy, Am. J. Psych. 158 (2001) 78-85.
36. L.N. Yatham, P.F. Liddle, J.Dennie, I.S. Shiah, M.J. Adam, C.J. Lane, R.W. Lam and T.J. Ruth, Arch. Gen. Psychiatry 56 (1999) 705-711.
37. D.H. Overstreet and G. Griebel, Eur. J. Pharmacol. 497 (2004) 49-53.
38. A.Zangen, D.H. Overstreet and G. Yadid J. Neurochem. 69 (1997) 2477-2483.
39. A. Zangen, D.H. Overstreet and G. Yadid (1999) Brain Res. 824 243-250.
40. F. Matrisciano, A. Caruso, R. Orlo, M. Marchiafava, V. Bruno, G. Battaglia, S.H. Gruber, D. Melchiorri, R. Tatarelli, P. Girardi, A.A. Mathe and F. Nicoletti, Neuropharmacology 55 (2008) 525-531.
41. R.S. Duman, G.R. Heninger and E.J. Nestler, Arch. Gen. Psychiatry 54 (1997) 597-606.
42. A. Watanabe, Y. Tohyama, K.Q. Nguyen, S. Hasegawa, G. Debonnel and M. Diksic, J. Neurochem. 85 (2003) 469-475.
43. S. Hasegawa, A. Watanabe, K.Q. Nguyen, G. Debonnel and Dik-sic, M. Psychopharmacol. (Berl). 179 (2005) 781-790.
44. H. van Riezen, H. Schnieden and A. F Wren, Br. J. Pharmacol. 60 (1977) 521-528.
45. J. Vetulani, F. Sulser, Nature 257 (1975) 495-496.
46. C. Song, B. Earley and B. E. Leonard, Brain Behav. Immun. 10 (1996) 1-16.
47. M. Cattarelli and A. Demael, Experientia 42 (2) (1986) 169-71.
48. D. Zhou, G. Grecksch, A. Becker, C. Frank, J. Pilz and G. Hu-ether, J. Neurosci. Res. 54 (1998) 109-116.
49. B. Robinzon, N. Snapir and M. Perek, Brain Res. Bull. 2 (1977) 263-271.
50. C. H. Vinkers, M. E. Breuer, K. G. Westphal, S. M. Korte, R. S. Oosting, B. Olivier and L. Groenink, Neuroscience 159 (2009) (1) 39-46.
51. H. van Riezen and B. E. Leonard, Pharmacol. Ther. 47 (1990) 21-34.
52. H.M. Kang, J. Jin, S. Lee, J. Ryu and C. Park, Neuroreport 21 (3) (2010) 179-184.
53. U. Dannlowski, P. Ohrmann, C. Konrad, K. Domschke, J. Bauer, H. Kugel, C. Hohoff, S. Schoning, A. Kersting, B.T. Baune, L.S. Mortensen, V. Arolt, P. Zwitserlood, J. Deckert, W. Heindel and T. Suslow, Int. J. Neuropsychopharmacol. 12 (2009) 11-22.
54. A. S. Wrynn, C. P. Mac Sweeney, F. Franconi, L. Lemaire, D. Pouliquen, S. Herlidou, B. E. Leonard, J. Gonde and J. D. Cer-taines, Brain Res. 879 (2000) 193-199.
55. K. Jaako-Movits, T. Zharkovsky, M. Pedersen and A. Zhark-ovsky, Cell Mol. Neurobiol. 26 (2006) 1559-1570.
56. C.H. Kellner, D.R. Rubinow and R.M. Post, J. Affect. Disord. 10 (1986) 215-219.
57. A. Saitoh, K. Yamaguchi, Y. Tatsumi, H. Murasawa, A. Naka-tani, N. Hirose, M. Yamada, Yamada and J. Kamei, Psy-chopharmacology (Berl) 191 (2007) 857-865.
58. D. Klein and T.S. Brown, J. Comp. Physiol. Psychol. 68 (1969) 107-110.
59. S. Hozumi, O. Nakagawasai, K. Tan-No, F. Niijima, F. Ya-madera, A. Murata, Y. Arai, H. Yasuhara, and T. Tadano, Behav. Brain Res. 138 (2003) 9-15.
60. M. Diksic, S. Nagahiro and T.L. Sourkes, J. Neural. Transm., Suppl 29 (1990) 131-140.
61. M. Diksic, S. Nagahiro, T.L. Sourkes and Y.L. Yamamoto, J. Cereb. Blood Flow Metab. 10 (1990) 1-12.
62. I.V. Nesterova, E.V. Gurevich, V.I. Nesterov, N.A. Otmakhova and N.V. Bobkova, Prog. Neuropsychopharmacol. Biol. Psychiatry 21 (1997) 127-140.
63. K.Q. Nguyen, Y. Tohyama, A. Watanabe, S. Hasegawa, I. Skelin and M. Diksic, Neurochem. Int. 54 (2009) 161-171.
64. G. Grecksch, D. Zhou, C. Franke, U. Schroder, B. Sabel, A. Becker and G. Huether, Br. J. Pharmacol. 122 (1997) 1725-1731.
65. K. Kato, T. Awasaki, K. Ito, Development 136 (2009) 51-59.
66. M. Kadekaro, W.H. Vance, M.L. Terrell, H. Gary, Jr., H.M. Ei-senberg and L. Sokoloff, Proc. Natl. Acad. Sci. USA 84 (1987) 5492-5495.
67. I. Skelin, H. Sato and M. Diksic, Brain Res. Bull. 76 (2008) 485-492.
68. H. M. van der Stelt, M. E. Breuer B. Olivier and H. G. Westenberg, Biol. Psychiatry 57 (2005) 1061-1067.
69. I. Skelin, H. Sato, T. Kovačevic and M. Diksic, Psychopharma-col. (Berl) (2009) 207 (2) 315-323.
70. I. Skelin, H. Sato and M. Diksic, Brain Res. 1310 (2010) 162-171.
71. A.C. Shakesby, R. Anwyl and M.J. Rowan, J. Neurosci. 22 (2002) 3638-3644.
72. A. Watanabe, S. Hasegawa, K. Nishi, K. Q. Nguyen and M. Diksic, Brain Res. Bull. 69 (2006), (2), 101-108.
73. D. Healy, P.A. Carney and B.E. Leonard, J. Psychiatr. Res. 17 (1982) 251-260.
74. C.V. Masini, P.V. Holmes, K.G. Freeman, A.C. Maki and G.L. Edwards, Physil. Behav. 81 (2004)111-119.
75. R.B. Lingham and Z. Gottesfeld, J. Neurosci. 6 (1986) 2208-2214.
76. G.G. Nomikos, A.P. Zis, G. Damsma, H.C Fibiger, Psy-chopharmacology 105 (1991) 230-238.
77. A.S. Brown and S. Gershon, J Neural Transm Gen. Sect. 91 (1993) 75-109.
78. B.J. Ciliax, C. Heilman, L.L. Demchyshyn, Z.B. Pristupa, E. Ince, S.M. Hersch, H.B. Niznik and A.I. Levey, J. Neurosci. 15 (1995) 1714-1723.
79. P.L. Mc Geer, J.C. Eccles, E.G. Mc Geer, Molecular neurobiol-ogy of the mammalian brain. Plenum Press, 1987, New York.
80. D.T. Monaghan, R.J. Bridges and C.W. Cotman, Ann. Rev. Pharmacol. Toxicol. 29 (1989) 365-402.
81. J.M. Wieronska, B. Legutko, D. Dudys and A. Pilc, Pharmacol. Rep. 60 (2008) 844-855.
82. Y.-J. Ho, Y.-C. Chang, T.-M. Liu, M.-Y. Tai, C.-S. Wong, Y.-F. Tsai, Neuroscience Letters 287 (2000) 11-120.
83. M.T. Lowy, L. Gault, and B.K. Yamamoto, J. Neurochem. 61 (1993) 1957-1960.
84. K.D. Cairncross, A. Wren, B. Cox, and H. Schnieden, Physiol. Behav. 19 (1977) 485-487.
85. J. M. Wieronska, B. Szewczyk, P. Branski, A. Palucha and A. Pilc, Amino Acids 23 (2002) 213-216.
86. A. Palucha, P. Branski, B. Szewczyk, J. M. Wieronska, K. Klak and A. Pilc, Pharmacol. Biochem. Behav. 81 (2005) 901-906.
87. K. Takahashi, H. Murasawa, K. Yamaguchi, M. Yamada, A. Na-katani, M. Yoshida, T. Iwai, M. Inagaki and A. Saitoh, Behav. Brain Res. 216 (2011) 46-52.
88. Y. Ho, T. Liu, M. Tai, Z. Wen, R.S. Chow, Y. Tsai and C. Wong, Brain Res. 900 (2001) 214-218.
89. M. Robichaud, V. Beauchemin, N. Lavoie, T. Dennis and G. De-bonnel, Synapse 42 (2001) 95-103.
90. T. Tadano, S. Hozumi, F. Yamadera, A. Murata, F. Niijima, K. Tan-No, O. Nakagawasai and K. Kisara, Methods Find. Exp. Clin. Pharmacol. 26 (2004) 93-97.
91. H.Araki, K. Suemaru and Y. Gomita, Jpn. J. Pharmacol. 88 (2002) 133-138.
92. H. Yoshimura, Y. Gomita and S. Ueki, Pharmacol. Biochem. Behav. 2 (1974) 703-705.
93. F. Han, N. Shioda, S. Moriguchi, Y. Yamamoto, A.Y. Raie, Y. Yamaguchi, M. Hino, K and Fukunaga, J. Pharmacol. Exp. Ther. 326 (2008) 127-134.
94. A. Nakajima, T. Yamakuni, M. Haraguchi, N. Omae, S.-Y. Song, C. Kato, O. Nakagawasai, T. Tadano, A. Yokosuka, Y. Mimaki, Y. Sashida and Y. Ohizumi, J. Pharmacol. Sci. 105 (2007) 122-126.
95. S.D. Norrholm and C.C. Ouimet. Synapse 42 (2001) 151-163.
96. M.H. Millan, S. Patel and B.S. Meldrum, Brain Res. 398 (1986) 204-206.
97. M. Muramatsu, J. Tamaki-Ohashi, C. Usuki, H. Araki and H. Aihara, Neuropharmacol. 27 (1988) 603-609.
98. I.Y. Aleksandrova, V.V. Kuvichkin, I.A. Kashparov, N.I. Med-vinskaya, I.V. Nesterova, S.M. Lunin, A.N. Samokhin and N.V. Bobkova, Biochemistry (Mosc) 69 (2004) 176-180.
99. M. Heilig and E. Widerlöv, Acta Psychiatr. Scand. 82 (1990) 95-114.
100. N. J. Rutkoski, A. A. Lerant, C. M. Nolte, J. Westberry and C. W. Levenson, Brain Res. (2002) 951 (1), 69-76.
101. I. Tasset, R. Drucker-Colin, J. Pena, I. Jimena, P. Montilla, F. J. Medina and I. Tunez, Neurochem. Res. 35 (2010) 1182-1187.
102. A. Zafir and N. Banu, Eur. J. Pharmacol. 572 (2007) (1), 23-31.
103. F. Karege, G. Vaudan, M. Schwald, N. Perroud and R. La Harpe, Brain Res. Mol. Brain Res. 136 (2005) 29-37.
104. K.R. Luo, C.J. Hong, Y.J. Liou, S.J. Hou, Y.H. Huang and S.J. Tsai, Prog. Neuropsychopharmacol. Biol. Psychiatry 34 (2010) 1433-1439.
105. B. Chen, D. Dowlatshahi, G.M. MacQueen, J.F. Wang and L.T. Young, Biol. Psychiatry 50 (2001) 260-265.
106. P. Vieyra-Reyes, Y. S. Mineur, M. R. Picciotto, I. Tunez, R. Vi-daltamayo and R. Drucker-Colin, Brain Res Bull 77 (2008) 13-18.
107. A. Saitoh, M. Yamada, K. Takahashi, K. Yamaguchi, H. Mu-rasawa, A. Nakatani, Y. Tatsumi, N.Hirose and J. Kamei, Brain Res 1208 (2008) 160-169.
108. D.S. Janowsky, C. Risch, D. Parker, L. Huey and L, Judd, Psy-chopharmacol. Bull. 16 (1980) 29-31.
109. O. Pucilowski and D.H. Overstreet, Brain Res.Bull. 32 (1993) 471-475.
110. R.D. Porsolt, P.M. Le and M. Jalfre, Nature 266 (1977) 730-732.
111. L. Prut and C. Belzung, Eur. J. Pharmacol. 463 (2003) 3-33.
112. G.D. Schiller, L.C. Daws, D.H. Overstreet and J. Orbach, Brain Res. Bull. 26 (1991) 433-435.
113. P. Willner, R. Muscat and M. Papp, Clin. Neuropharmacol. 15 (1992) Suppl 1 Pt A: 550A-551A.
114. K. Matthews, B.A. Baldo, A. Markou, O. Lown, D.H. Overstreet and G.F. Koob, Physiol. Behav. 59 (1996) 1155-1162.
115. I. Roth-Deri, A. Friedman, L. Abraham, E. Lax, Y. Flaumenhaft, Y. Dikshtein and G. Yadid, Eur. J. Neurosci. 30 (2009) 485-492.
116. M.P. Austin, P. Mitchell and G.M. Goodwin, Br. J. Psychiatry 178 (2001) 200-206.
117. R.M. Benca, D.E. Overstreet, M.A. Gillil, D. Russell, B.M. Bergmann and W.H. Obermeyer, Neuropsychopharmacol. 15 (1996) 45-51.
118. P.J. Shiromani, J.C. Gillin and S.J. Henriksen, Annu. Rev. Pharmacol. Toxicol. 27 (1987) 137-156.
119. J. Adrien, Sleep Med. Rev. 6 (2002) 341-351
120. E.M. Friedman, K.A. Becker, D.H. Overstreet and D.A. Lawrence, Psychosom. Med. 64 (2002) 267-273.
121. P. Willner, Prog. Neuropsychopharmacol. Biol. Psychiatry, 10 (1986) 677-690.
122. N. Liebenberg, B.H. Harvey, L. Brand and C.B. Brink, Behav. Pharmacol. 21 (2010) 540-547.
123. N. Kokras, K. Antoniou, C. Dalla, S. Bekris, M. Xagoraris, D.H. Ovestreet and Z. Papadopoulou-Daifoti, J. Psychopharmacol. 23 (2009) 945-956.
124. A. Zangen, R. Nakash, D.H. Overstreet and G. Yadid, Psycho-pharmacol. (Berl) 155 (2001) 434-439.
125. Y. Tizabi D.H. Overstreet A.H. Rezvani V.A. Louis, E. Jr. Clark, D.S. Janowsky and M.A. Kling, Psychopharmacol (Berl) 142 (1999) 193-199.
126. D.H. Overstreet, J. Stemmelin and G. Griebel, Pharmacol. Bio-chem Behav. 89 (2008) 623-626.
127. D.H. Overstreet, O. Pucilowski, M.C. Retton, P. Delagrange and B. Guardiola-Lemaitre, Neuroreport 9 (1998) 249-253.
128. D.H. Overstreet, A. Keeney and S. Hogg, Eur. J. Pharmacol. 492 (2004) 195-201.
129. D.H. Overstreet, V.M. Naimoli and G. Griebel, Pharmacol. Bio-chem. Behav. 96 (2010) 206-210.
130. H. Einat, R.H. Belmaker, A. Zangen, D.H. Overstreet and G. Yadid, Depress. Anxiety. 15 (2002) 148-151.
131. D.H. Overstreet, R.W. Russell, A.D. Crocker and G.D. Schiller, Brain Res. 294 (1984) 327-332.
132. D.H. Overstreet, O Pucilowski, A.H. Rezvani and D.S. Ja-nowsky, Psychopharmacol. (Berl) 121 (1995) 27-37.
133. S. Hasegawa, K. Nishi, A.Watanabe, D.H. Overstreet and M. Diksic, Neurochem. Int. 48 (2006) 358-366.
134. M. Diksic and S.N. Young, J. Neurochem. 78 (2001) 1185-1200.
135. H. Okazawa, F. Yamane, P. Blier and M. Diksic, J. Neurochem. 72 (1999) 2022-2031.
136. Y. Tohyama, F. Yamane, M.F. Merid and M. Diksic Europ Neuropsychopharmacol 11 (2001) 193-202.
137. Y. Tohyama, F. Yamane, M.M. Fikre, P. Blier and M. Diksic, J. Neurochem. 80 (2002) 788-798.
138. S. Hasegawa, A. Watanabe, K. Nishi, K.Q. Nguyen and M. Diksic, Neurochem. Int. 46 (2005) 261-272.
139. C.F. Dobson, Y. Tohyama, M. Diksic and E. Hamel, Cephalalgia 24 (2004) 2-11.
140. C. Moret, M. Briley, Naunyn Schmiedebergs Arch Pharmacol. 351 (1995) 377-384.
141. K. Kanemaru, S. Hasegawa, K. Nishi and M. Diksic, Brain Res. Bull. 77 (2008) 214-220.
142. K. Kanemaru, K. Nishi and M. Diksic Neurochem. Int. 55 (2009) 529-535.
143. K. Nishi, K. Kanemaru, S. Hasegawa, A. Watanabe and M. Diksic, Neurochem. Int. 54 (2009) 205-214.
144. J.B. Macon, L. Sokoloff and J. Glowinski, J. Neurochem. 18 (1971) 323-331.
145. L. Sokoloff, Brain 102 (1979) 653-668.
146. J.J. Grome and A.M. Harper J. Neurochem. 46 (1986) 117-124.
147. P. Yarowsky, M. Kadekaro and L. Sokoloff Proc. Natl. Acad. Sci. U.S.A 80 (1983) 4179-4183.
148. L. Serova, E.L. Sabban, A. Zangen, D.H. Overstreet and G. Yadid, Brain Res. Mol. Brain Res. 63 (1998) 133-138.
149. K. Schwartz, G. Yadid, A. Weizman and M. Rehavi, Brain Res. 965 (2003) 174-179.
150. M.F. Roitman, R.A. Wheeler, R.M. Wightman and R.M. Carelli, Nat. Neurosci. 11 (2008) 1376-1377.
151. D. Sabatinelli, M.M. Bradley, P.J. Lang, V.D. Costa and F. Versace J. Neurophysiol. 98 (2007) 1374-1379.
152. S. Pepe, D.H. Overstreet and A.D. Crocker, Pharmacol. Bio-chem. Behav. 31 (1988) 15-19.
153. H.K. Manji Quiroz J. Sporn J.L. Payne K. Denicoff A. Gray, C.A. Zarate Jr. and D.S. Charney, Biol. Psychiatry 53 (2003) 707-742.
154. F. Chen, T.M. Madsen, G. Wegener and J.R. Nyengaard, Hippocampus 20 (2009) 1376-1384.
155. B. Elfving, P.H. Plougmann, H.K. Muller, A.A. Mathe, R. Rosenberg and G. Wegener, Int. J. Neuropsychopharmacol. 13 (2010) 563-572.
156. P. Green, N. Anyakoha, G. Yadid, I. Gispan-Herman and A. Nicolaou, Prostaglins Leukot. Essent. Fatty Acids 80 (2009) 213-220.
157. D.H. Overstreet, A.H. Rezvani and D.S. Janowsky, Biol. Psychiatry 31 (9) (1992) 919-936.
158. T.C. Eley, K. Sugden, A. Corsico, A.M. Gregory, P. Sham, P. McGuffin, R. Plomin andI.W. Craig, Mol. Psych. 9 (2004) 908-915.
159. R.L. Sjöberg, K.W. Nilsson, N. Nordquist, J. Ohrvik, J. Leppert, L. Lindström and L. Orel, Int. J. Neuropsychopharmacol. 9 (2006) 443-449.
160. M.C. Moffett, A. Vicentic, M. Kozel, P. Plotsky, D.D. Francis and M.J. Kuhar, Biochem. Pharmacol. 73 (2007) 321-30.
161. A. Holmes, A.M. le Guisquet, E. Vogel, R.A. Millstein, S. Leman and C. Belzung, Neurosci. Biobehav. Rev. 29 (2005) 1335-1346.
162. C. Piubelli, M. Vighini, A.A. Mathé, E. Domenici and L. Carboni, Int. J. Neuropsychopharmacol. (2010) 1-38;
163. C. Piubelli, M. Vighini, A.A. Mathé, E. Domenici and L. Carboni, Int. J. Neuropsychopharmacol. (2010) 1-22;
164. L. Carboni, S. Becchi, C. Piubelli, A. Mallei, R. Giambelli, M. Razzoli, A.A. Mathé, M. Popoli and E. Domenici, Prog. Neurop-sychopharmacol. Biol. Psychiatry 34 (2010) 1037-1048.